Examkin

Soru

Zorluk: ZorDepressive Disorders

A 68-year-old woman is evaluated in the outpatient clinic for an acute episode of major depressive disorder without psychotic features. Over the course of the next year, her condition proves highly resistant to standard therapies, eventually culminating in severe clinical deterioration. Arrange the following clinical management steps in the correct evidence-based chronological sequence, reflecting the standard escalation of psychiatric care from initial presentation to the eventual onset of life-threatening psychotic depression with severe food refusal.

  1. 1Initiate first-line monotherapy with an SSRI (e.g., sertraline)
  2. 2Switch to a different antidepressant class (e.g., SNRI) after 6 weeks of non-response
  3. 3Augment the regimen with a second-generation antipsychotic after a partial response
  4. 4Admit to an acute inpatient psychiatric unit due to new-onset delusions and food refusal
  5. 5Initiate a course of electroconvulsive therapy (ECT)

Cevap

The correct chronological sequence of management is: 1. Initiate first-line monotherapy with an SSRI; 2. Switch to a different antidepressant class (e.g., SNRI) after 6 weeks of non-response; 3. Augment the regimen with a second-generation antipsychotic after a partial response; 4. Admit to an acute inpatient psychiatric unit due to new-onset delusions and food refusal; 5. Initiate a course of electroconvulsive therapy (ECT).
The sequence accurately reflects standard USMLE algorithms for escalating depression treatment. Initially, an SSRI is the preferred first-line agent. Complete non-response after an adequate 4-6 week trial prompts a switch to a different agent (e.g., SNRI). If the second agent provides a partial therapeutic response, augmentation (e.g., with aripiprazole or lithium) is appropriate to maximize benefit. If the patient's condition continues to worsen to the point of developing psychotic features or refusing food, outpatient management becomes inherently unsafe, mandating immediate inpatient psychiatric admission. Finally, in the setting of severe psychotic depression with life-threatening food refusal, ECT is the most rapid and effective definitive intervention.

Adım Adım Çözüm

1
Establish first-line treatment for an initial major depressive episode.
Initiate SSRI monotherapy.
SSRIs offer the best balance of efficacy and tolerability for initial outpatient treatment.
2
Address complete non-response at 6 weeks.
Switch to an SNRI.
A 4-6 week duration is an adequate trial. Complete absence of clinical improvement dictates switching to a different medication rather than augmenting.
3
Address partial response to the second antidepressant agent.
Augment with a second-generation antipsychotic.
Augmentation builds upon the partial efficacy achieved, avoiding the loss of gained therapeutic benefits that might occur with another switch.
4
Respond to acute safety risks and clinical decompensation.
Inpatient psychiatric admission.
The new onset of psychosis and food refusal poses an imminent threat to the patient's life, requiring a secure hospital setting for immediate stabilization.
5
Select definitive treatment for life-threatening psychotic depression.
Administer ECT.
ECT provides unmatched speed and efficacy for severe, refractory, or psychotic depression, especially when nutritional status is acutely compromised.

Anahtar Kavram

Stepped-care pharmacological management of Major Depressive Disorder (MDD) and indications for Electroconvulsive Therapy (ECT)
Tahmini Süre:1m 30s
Bu soruyu puanla

Konular

Depressive Disorders

Bu konudan daha fazla soru